RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Clinical trial NCT02303990 · COMPLETED
Trial details
- NCT number
- NCT02303990
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-08
- Primary completion
- 2018-12-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.